
Congress trades
Haemonetics Corporation (HAE)
NYSE · Healthcare · 13 congress trades · last filed 5 years ago
About Haemonetics Corporation
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Christopher A. Simon
- Employees
- 3,009
- Listed since
- May 10, 1991
- Market value
- $4.7B
- Price to earnings
- 50.1
- Earnings per share
- $2.12
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q1 FY2027reported Aug 6, 2026 | $1.14 | $1.08 | $339.4M | $327.9M | EPS beatRevenue beat |
| May 7, 2026 | $1.29 | $1.28 | $346.4M | $336.8M | EPS in lineRevenue beat |
| Q3 FY2026reported Feb 5, 2026 | $1.31 | $1.27 | $339.0M | $331.9M | EPS beatRevenue beat |
| Q2 FY2026reported Nov 6, 2025 | $1.27 | $1.12 | $327.3M | $329.8M | EPS beatRevenue in line |
| Q1 FY2026reported Aug 7, 2025 | $1.10 | $1.01 | $321.4M | $320.0M | EPS beatRevenue in line |
| May 8, 2025 | $1.24 | $1.22 | $330.6M | $312.5M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2026 · proxy filed Jun 9, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Christopher A. SimonPresident and Chief Executive Officer | $1.1M | $7.6M | $3.4M | $12.0M |
| James C. D'AreccaExecutive Vice President, Chief Financial Officer | $604K | $1.8M | $1.2M | $3.6M |
| Michelle L. BasilExecutive Vice President, General Counsel | $559K | $1.7M | $1.1M | $3.4M |
| Frank W. ChanExecutive Vice President, Chief Operating Officer | $518K | $1.5M | $1.3M | $3.3M |
| Roy GalvinExecutive Vice President, Chief Commercial Officer | $550K | $1.5M | $1.0M | $3.0M |
The summary compensation table from the 2026 proxy statement, current executives only. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $443.2M | 5,909,258 | +5.1% | 13.03% |
| Neuberger Berman Group LLC | $313.5M | 4,179,443 | +17.4% | 9.21% |
| Vanguard Portfolio Management LLC | $191.0M | 2,546,394 | -0.5% | 5.61% |
| AQR Capital Management LLC | $165.0M | 2,266,489 | -32.5% | 5.00% |
| Ariel Investments, LLC | $154.6M | 2,060,966 | +100.0% | 4.54% |
| Vanguard Capital Management LLC | $154.5M | 2,059,578 | -1.5% | 4.54% |
| State Street Corp | $136.4M | 1,818,186 | +2.6% | 4.01% |
| Dimensional Fund Advisors LP | $118.9M | 1,585,222 | +19.5% | 3.49% |
| Citadel Advisors LLC | $113.3M | 1,510,120 | +485.0% | 3.33% |
| Geode Capital Management, LLC | $96.6M | 1,287,240 | +5.6% | 2.84% |
| River Road Asset Management, LLC | $96.4M | 1,285,602 | -3.2% | 2.83% |
| Arrowstreet Capital, Limited Partnership | $86.7M | 1,155,351 | -16.5% | 2.55% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
Congress trades in HAE
13 disclosures of 13 on record · median 17d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +67.9%S&P +81.9% · vs S&P 500 -14.0% | May 6, 2021 | May 25, 2021 | 19d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +69.0%S&P +80.6% · vs S&P 500 -11.6% | May 7, 2021 | May 25, 2021 | 18d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | -16.2%S&P +98.4% · vs S&P 500 -114.6% | Jan 25, 2021 | Feb 9, 2021 | 15d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +10.0%S&P +119.7% · vs S&P 500 -109.7% | Oct 16, 2020 | Nov 5, 2020 | 20d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +19.6%S&P +124.2% · vs S&P 500 -104.6% | Sep 15, 2020 | Oct 13, 2020 | 28d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | +22.2%S&P +126.5% · vs S&P 500 -104.3% | Aug 14, 2020 | Aug 24, 2020 | 10d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -6.1%S&P +149.5% · vs S&P 500 -155.6% | Jun 1, 2020 | Jun 16, 2020 | 15d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +1.9%S&P +161.0% · vs S&P 500 -159.1% | May 19, 2020 | Jun 16, 2020 | 28d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | -6.7%S&P +151.7% · vs S&P 500 -158.4% | May 28, 2020 | Jun 10, 2020 | 13d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +2.8%S&P +166.5% · vs S&P 500 -163.7% | May 15, 2020 | Jun 10, 2020 | 26d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -2.2%S&P +167.1% · vs S&P 500 -169.4% | Aug 7, 2018 | Aug 24, 2018 | 17d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +7.7%S&P +173.7% · vs S&P 500 -166.0% | Jun 14, 2018 | Jun 22, 2018 | 8d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +11.2%S&P +175.1% · vs S&P 500 -163.9% | Jun 7, 2018 | Jun 22, 2018 | 15d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded HAE?
Lois Frankel, Josh Gottheimer, Gilbert Ray Cisneros, Jr. disclosed HAE transactions in the filings shown here.
How quickly are HAE trades disclosed?
Congressional disclosures took a median of 17 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
